World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
130
Citations
61154
World Ranking
2499
National Ranking
121

Overview

Peter Riederer is affiliated with the University of Würzburg in Germany and has an extensive research record in the fields of Medicine and Neuroscience. Their work prominently focuses on areas such as neurology, cellular and molecular neuroscience, molecular biology, epidemiology, and psychiatry and mental health.

The scientist's main research topics include:

  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Neurological Disorders and Treatments
  • Genetic Neurodegenerative Diseases
  • Neurological Disease Mechanisms and Treatments
  • Alzheimer's disease research and treatments
  • Tryptophan and brain disorders

Peter Riederer has contributed to a range of recent academic papers related to neurodegenerative diseases and neurological treatments. Selected recent publications include:

  • "Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials," 2021, Journal of Neural Transmission
  • "Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease," 2023, Journal of Neural Transmission
  • "Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials," 2021, Pharmaceuticals
  • "The role of alpha-synuclein as ferrireductase in neurodegeneration associated with Parkinson's disease," 2020, Journal of Neural Transmission
  • "The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels," 2021, Cells

The most frequent publication venue for their work is Journal of Neural Transmission, with 18 publications. Other notable venues include Cells, Preprints.org, Pharmaceuticals, and Expert Review of Clinical Pharmacology.

Collaboration plays a notable role in their research, with frequent co-authors including Jeswinder Sian-Hülsmann, Edna Grünblatt, Ștefan Strilciuc, Dana Boering, and Aleš Pražnikar. These collaborations have resulted in multiple joint publications contributing to the understanding of neurological diseases.

Best Publications

  • Allelic Variation of Human Serotonin Transporter Gene Expression

    A Heils;A Teufel;S Petri;G Stöber

  • Iron, brain ageing and neurodegenerative disorders

    Luigi Zecca;Moussa B. H. Youdim;Peter Riederer;James R. Connor

  • Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.

    Peter Riederer;Emin Sofic;Wolf-Dieter Rausch;Bruno Schmidt

  • Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients

    Makio Mogi;Minoru Harada;Peter Riederer;Hirotaro Narabayashi

  • Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients

    Doris Blum-Degen;Thomas Müller;Wilfried Kuhn;Manfred Gerlach

  • Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients

    Makio Mogi;Minoru Harada;Tomoyshi Kondo;Peter Riederer

  • Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

    E. Sofic;P. Riederer;H. Heinsen;H. Beckmann

  • Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

    L. Frölich;D. Blum-Degen;H.-G. Bernstein;S. Engelsberger

  • PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

    Bin Zheng;Zhixiang Liao;Joseph J. Locascio;Kristen A. Lesniak

  • Organization of the human serotonin transporter gene.

    K P Lesch;U Balling;J Gross;K Strauss

  • Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

    E. Sofic;Klaus W. Lange;K. Jellinger;Peter Riederer

  • Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

    M. Gerlach;P. Riederer

  • Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter.

    Klaus-Peter Lesch;Benjamin L. Wolozin;Dennis L. Murphy;Peter Riederer

  • Oxidative stress: Free radical production in neural degeneration

    Mario E. Götz;Gabriella Künig;Peter Riederer;Moussa B.H. Youdim

  • Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

    Vivianna M. Van Deerlin;Patrick M A Sleiman;Maria Martinez-Lage;Maria Martinez-Lage;Alice Chen-Plotkin

  • Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.

    E. Sofic;W. Paulus;K. Jellinger;P. Riederer

  • Brain iron and ferritin in Parkinson's and Alzheimer's diseases.

    K. Jellinger;W. Paulus;I. Grundke-Iqbal;P. Riederer

  • Human brain dopamine receptors in children and aging adults.

    Philip Seeman;Natalie H. Bzowej;H.-C. Guan;Catherine Bergeron

  • The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.

    W. Birkmayer;P. Riederer;M. B. H. Youdim;W. Linauer

  • Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.

    Nuria Durany;Tanja Michel;Robert Zöchling;Karl W Boissl

Frequent Co-Authors

Edna Grünblatt
Edna Grünblatt University of Zurich
Johannes Kornhuber
Johannes Kornhuber University of Göttingen
Moussa B.H. Youdim
Moussa B.H. Youdim Technion – Israel Institute of Technology
Kurt A. Jellinger
Kurt A. Jellinger Medical University of Vienna
Jürgen Deckert
Jürgen Deckert University of Würzburg
Klaus-Peter Lesch
Klaus-Peter Lesch University of Würzburg
Kay L. Double
Kay L. Double University of Sydney
Gavin P. Reynolds
Gavin P. Reynolds Sheffield Hallam University
Helmut Heinsen
Helmut Heinsen University of Würzburg
Luigi Zecca
Luigi Zecca National Academies of Sciences, Engineering, and Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and supplementary career paths in healthcare can broaden your options beyond medical school. One popular route is a health administration degree, which prepares graduates for leadership roles in hospitals, clinics, and healthcare organizations.

If you are seeking advanced administrative opportunities, an affordable master’s program can be the next step. Many students look for cheap mha programs to gain high-level management skills while minimizing student debt.

For those interested in advanced clinical practice, pursuing a Doctor of Nursing Practice can open new doors. With the rising costs of education, there is strong interest in the cheapest dnp online programs that offer flexibility and affordability.

Pharmacy is another respected healthcare profession with online education pathways. Students interested in this field often search for online pharmacist programs to advance their knowledge and credentials with more accessible study options.

These online degrees provide diverse entry points into dynamic health careers, making them a valuable consideration for anyone planning a future in medicine or healthcare.

Best Scientists Citing Peter Riederer

Trending Scientists

Recently Published Articles